Unlikely to cause harm — often a labeling or packaging issue.
Labeling: Incorrect or missing package insert.
| Brand name | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE |
| Generic name | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE |
| Active ingredient(s) | DEXAMETHASONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE |
| Distributed by / for | Sandoz Inc |
| NDC | 61314-630-06 |
| Full product label | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, Rx Only, Sterile, 5 mL bottle, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc. Princeton, NJ 08540, NDC 61314-630-06 |
| Recalling firm | Sandoz Inc |
| Distribution | Nationwide in the U.S. |
| Quantity | 346,929 bottles |
| Recall initiated | 2019-10-17 |
| Report date | 2019-11-06 |
| Recall completed | 2022-01-19 |
| Recall number | D-0162-2020 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗